Ribavirin, Its Dosing Regime

Summary

Ribavirin, Its Dosing Regime is a clinical trial^[1].

Key Facts

• Ribavirin, Its Dosing Regime is in the country of Netherlands^[2].
• Ribavirin, Its Dosing Regime's instance of is recorded as clinical trial^[3].
• Ribavirin, Its Dosing Regime's start time is recorded as +2007-07-31T00:00:00Z^[4].
• Ribavirin, Its Dosing Regime's end time is recorded as +2012-12-31T00:00:00Z^[5].
• Ribavirin, Its Dosing Regime's main subject is recorded as pharmacokinetics^[6].
• Ribavirin, Its Dosing Regime's main subject is recorded as hepatitis C^[7].
• Ribavirin, Its Dosing Regime's main subject is recorded as hepatitis^[8].
• Ribavirin, Its Dosing Regime's number of participants is recorded as {'unit': '1', 'amount': '+15'}^[9].
• Ribavirin, Its Dosing Regime's title is recorded as Ribavirin, Its Dosing Regime^[10].
• Ribavirin, Its Dosing Regime's short name is recorded as Ribados^[11].
• Ribavirin, Its Dosing Regime's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[12].
• Ribavirin, Its Dosing Regime's ClinicalTrials.gov ID is recorded as NCT00484328^[13].
• Ribavirin, Its Dosing Regime's research intervention is recorded as ribavirin^[14].
• Ribavirin, Its Dosing Regime's clinical trial phase is recorded as phase IV clinical trial^[15].
• Ribavirin, Its Dosing Regime's research site is recorded as Maastricht University^[16].
• Ribavirin, Its Dosing Regime's research subject recruitment status is recorded as completed^[17].
• Ribavirin, Its Dosing Regime's study type is recorded as interventional study^[18].